Woodline Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Buy |
+514,381
| New | +$32.5M | 0.17% | 169 |
|
|
2024
Q4 | – | Sell |
-143,823
| Closed | -$7.53M | – | 985 |
|
|
2024
Q3 | $7.53M | Buy |
143,823
+99,576
| +225% | +$5.22M | 0.06% | 336 |
|
|
2024
Q2 | $1.82M | Sell |
44,247
-127,960
| -74% | -$5.25M | 0.02% | 424 |
|
|
2024
Q1 | $7.46M | Buy |
172,207
+97,357
| +130% | +$4.22M | 0.07% | 310 |
|
|
2023
Q4 | $3.44M | Buy |
+74,850
| New | +$3.44M | 0.04% | 347 |
|